ABT · News · 20261102N

Healthcare Coverage Policy

ABBOTT LABORATORIES · 2026-11-02 · Importance 26 · Surprise 24

Medicare plans to expand continuous glucose monitor coverage to Type 2 diabetes patients who are not on insulin, with a CMS decision expected soon, according to the report. Abbott anticipates a slowdown and pricing pressures ahead of the coverage expansion. A pharmacy benefit manager is also making a formulary change that will shift coverage from Dexcom to Abbott for some customers in 2027.